0001140361-12-041282.txt : 20120924 0001140361-12-041282.hdr.sgml : 20120924 20120924145106 ACCESSION NUMBER: 0001140361-12-041282 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120920 FILED AS OF DATE: 20120924 DATE AS OF CHANGE: 20120924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lieber Jonathan I CENTRAL INDEX KEY: 0001350090 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 121106132 MAIL ADDRESS: STREET 1: C/O ALTUS PHARMACEUTICALS INC. STREET 2: 125 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 3 1 doc1.xml FORM 3 X0206 3 2012-09-20 0 0000730272 REPLIGEN CORP RGEN 0001350090 Lieber Jonathan I C/O REPLIGEN CORPORATION 41 SEYON ST, BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 CFO Common Stock 15000 D Stock Option (Right to Buy) 5.98 2022-09-22 Common Stock 110000 D 15,000 shares will vest on September 20, 2013. 22,000 shares vest and become exercisable on each of the following dates: 9/20/2013, 9/20/2014, 9/20/2015, 9/20/2016 and 9/20/2017. /s/ Jonathan I. Lieber (Attorney in Fact) 2012-09-24